A new analysis from independent journalist group ProPublica, which has been critical of physician/pharmaceutical company collaborations in past reports, finds that major drug firms are dramatically cutting the amount they spend on physicians for promotional speaking gigs. Among the major players the watchdog group says are slashing speaker fees is Eli Lilly and Co., which spent 55 percent less in 2012 than the almost $48 million it spent in 2011. Pfizer reduced speaker fees by 62 percent, ...

Register for FREE Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Pharma Speaker Payments on the Decline, you'll get exclusive access to a large archive of premium content.

Already registered? here.